Stockreport

Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting [...

Anixa Biosciences, Inc.  (ANIX) 
Last anixa biosciences, inc. earnings: 3/9 05:10 pm Check Earnings Report
PDF Protocol defined immune responses were exhibited in over 70% of patients A Phase 2 study evaluating the vaccine in the neoadjuvant setting is planned to commence in 2 [Read more]